GlassScriptPhysician profile
Whitney E George
NPI 1639834989
$3,468.92
in general payments reported to CMS, 2019-2025
37 companies · $791 in 2025
The $791 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $1,088 · 2023: $570 · 2024: $898 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $685.92 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $322.83 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Dexcom, INC. | $271.62 | 2023-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $252.20 | 2022-2025 | Caplyta |
| Glaxosmithkline, LLC. | $218.94 | 2023-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $212.69 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.56 | 2022-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $138.46 | 2022 | |
| Abbott Laboratories | $127.74 | 2024-2025 | Freestyle Libre 3, Absorb Gt1 |
| Optinose US, INC. | $99.06 | 2021 | |
| Axsome Therapeutics, INC. | $91.87 | 2024-2025 | Auvelity |
| Amgen INC. | $82.56 | 2022-2024 | Repatha, Otezla |
| Lilly USA, LLC | $76.87 | 2022-2025 | Mounjaro, Jardiance |
| Vanda Pharmaceuticals INC. | $63.58 | 2025 | Fanapt |
| Astellas Pharma US INC | $63.12 | 2023-2024 | Veozah, Myrbetriq |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.